Navigation Links
Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe
Date:6/24/2011

ecommendation, we believe linagliptin can be an important new treatment option for adult patients with type 2 diabetes."

About Diabetes

Approximately 25.8 million Americans(1) and an estimated 220 million people worldwide(2) have type 1 and type 2 diabetes. Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.(1) Diabetes is a chronic disease that occurs when the body either does not properly produce, or use, the hormone insulin.(3)

What is TRADJENTA?

TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

TRADJENTA is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

It is not known if TRADJENTA is safe and effective when used with insulin.

Important Safety Information

Who should not take TRADJENTA?

Do not take TRADJENTA if you are allergic to linagliptin or any of the ingredients in TRADJENTA.  

Symptoms of a serious allergic reaction to TRADJENTA are rash, raised red patches on your skin (hives), swelling of your face, lips, and throat that may cause difficulty breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking TRADJENTA and call your doctor right away.

What should I tell my doctor before taking TRADJENTA?

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Tell your doctor if you take other medicines that can lower your blood sugar, such as a sulfonylurea or insulin. If you take TRADJENTA with another medicine that can cause low blood sugar (hypoglycemia), such as a sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea medicine or insulin may ne
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
2. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
3. Catheterization Recommended for Treating Pediatric Heart Conditions
4. BYDUREON™ Recommended for Approval in Europe
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
7. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
8. Half of All Women Do Not Get Regular Mammograms Despite Recommended Guidelines
9. Encisions Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
10. DaTSCAN™ (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimers Disease
11. Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... N.C. , June 21 Gentris Corporation ... pharmacogenomics, announced today that Rick Williams has ... member of the Board of Directors.  In his role ... company,s scientific leadership continues to provide biotechnology and pharmaceutical ...
... LONDON , June 21 Thomson Reuters announced ... innovative resource designed to change the way biotechnology, pharmaceutical and academic ... , , ... available free to all organizations with drugs in development. It enables ...
Cached Medicine Technology:Gentris Corporation Names New Chief Executive Officer 2Gentris Corporation Names New Chief Executive Officer 3Gentris Corporation Names New Chief Executive Officer 4Thomson Reuters Creates The Outpartnering Registry, a Free Resource to Improve Drug Development Partnering 2Thomson Reuters Creates The Outpartnering Registry, a Free Resource to Improve Drug Development Partnering 3
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her ... the leading network of doctors working on a lien basis. Dr. Lim had ... , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain herself ...
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site ... and other serious medical conditions. Screenings are affordable and accurate and run about ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... ... CA area, Carlson & Associates has once again teamed up with Family Emergency ... homeless families to move toward self-sufficiency. FESCO was created especially to provide emergency ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... suffer from musculoskeletal injuries and conditionsLAS VEGAS, Feb. 25 ... and conditions affect our quality of life every day. ... Surgeons, (AAOS) 2009 multimedia Public Service Advertising Campaign is ... scoliosis and preventing injuries in female athletes, knees. ...
... Study finds many children at risk for foot deformity due ... children are wearing shoes that are too small, according to ... of the American Academy of Orthopaedic Surgeons ( ... at high risk for developing serious foot deformities.The study, which ...
... Molecular Oncology (MOLONC) ( http://www.elsevier.com/locate/molonc ), published ... European Biochemical Societies (FEBS), has been accepted by ... Science Citation Index Expanded (SciSearch), Biosis Previews and ... times a year from January 1, 2009) highlights ...
... EAST RUTHERFORD, N.J., Feb. 25 CCA Industries, Inc. ... fiscal year ended November 30, 2008 were $57,457,946, net ... were $0.20. Revenues for the prior year were ... per share were $0.78. Revenues for the fourth ...
... University of Texas M. D. Anderson ... Gamma Knife (R) Perfexion(TM), an advanced ... or more lesions in the head in a ... http://www.newscom.com/cgi-bin/prnh/20090225/CL74742 )"Leksell Gamma Knife Perfexion suits our ...
... Feb. 20 CUREXO Technology Corporation, pioneer in ... products for orthopaedic applications, which is focused on ... has submitted a premarket notification 510(k) application to ... market clearance in the U.S. for use of ...
Cached Medicine News:Health News:The Most Breaking News in the Joint 2Health News:The Most Breaking News in the Joint 3Health News:The Most Breaking News in the Joint 4Health News:If the Shoe Fits...or Does It? 2Health News:If the Shoe Fits...or Does It? 3Health News:Molecular Oncology accepted into Thomson Reuters index 2Health News:CCA Industries, Inc Announces Year End Results 2Health News:CCA Industries, Inc Announces Year End Results 3Health News:M. D. Anderson Cancer Center Acquires Leksell Gamma Knife Perfexion for Targeted Brain Lesion Treatments 2Health News:M. D. Anderson Cancer Center Acquires Leksell Gamma Knife Perfexion for Targeted Brain Lesion Treatments 3Health News:CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application 2
... The optomap is the companys core product. ... used in primary level eye care for the ... It is available on a pay-per-patient examination basis ... with a digital wide-field of view of the ...
... Cardiac Digital Camera is a state-of-the-art, office-based nuclear ... and provides full sized fields of view. ... you need a flexible system that can work ... how the Pulse reduces the costs of adding ...
... same cryoconsole and platform technology as Freezor ... veins. Arctic Circler is an ablation tool ... that rely on medication., ,With its ... the ability to create curvilinear lesions rapidly ...
... Coil is intended for: embolization of those ... their location, or the patient's general medical ... team to be a) very high risk ... b) inoperable.,The GDC is also intended for ...
Medicine Products: